Danaher Corp. (DHR) Position Cut by Sanders Morris Harris Inc.
Sanders Morris Harris Inc. cut its position in Danaher Corp. (NYSE:DHR) by 25.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,381 shares of the company’s stock after selling 825 shares during the period. Sanders Morris Harris Inc.’s holdings in Danaher Corp. were worth $240,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Nomura Asset Management Co. Ltd. increased its position in shares of Danaher Corp. by 0.6% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 68,388 shares of the company’s stock worth $6,352,000 after buying an additional 431 shares in the last quarter. DnB Asset Management AS increased its position in Danaher Corp. by 52.1% in the first quarter. DnB Asset Management AS now owns 60,755 shares of the company’s stock valued at $5,763,000 after buying an additional 20,800 shares during the period. CENTRAL TRUST Co bought a new position in Danaher Corp. during the first quarter valued at about $1,749,000. Fjarde AP Fonden Fourth Swedish National Pension Fund increased its position in Danaher Corp. by 14.9% in the first quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 143,158 shares of the company’s stock valued at $13,580,000 after buying an additional 18,596 shares during the period. Finally, Exxonmobil Investment Management Inc. TX increased its position in Danaher Corp. by 8.9% in the first quarter. Exxonmobil Investment Management Inc. TX now owns 145,556 shares of the company’s stock valued at $13,807,000 after buying an additional 11,923 shares during the period. Institutional investors and hedge funds own 75.83% of the company’s stock.
Shares of Danaher Corp. (NYSE:DHR) traded down 0.30% during trading on Friday, reaching $76.57. The company had a trading volume of 8,103,652 shares. Danaher Corp. has a 52 week low of $61.60 and a 52 week high of $82.64. The firm has a market capitalization of $52.87 billion, a price-to-earnings ratio of 15.23 and a beta of 1.13. The firm has a 50-day moving average of $80.65 and a 200 day moving average of $75.68.
Danaher Corp. (NYSE:DHR) last posted its earnings results on Monday, July 25th. The company reported $1.25 EPS for the quarter, topping the Zacks’ consensus estimate of $1.22 by $0.03. The company had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.76 billion. Danaher Corp. had a return on equity of 13.40% and a net margin of 15.88%. Danaher Corp.’s quarterly revenue was up 16.6% compared to the same quarter last year. During the same period in the previous year, the business earned $1.08 earnings per share. On average, equities research analysts forecast that Danaher Corp. will post $3.56 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, September 30th will be given a $0.125 dividend. The ex-dividend date is Wednesday, September 28th. This represents a $0.50 annualized dividend and a dividend yield of 0.65%. Danaher Corp.’s dividend payout ratio is currently 12.72%.
DHR has been the topic of several research reports. Bank of America Corp. reiterated a “buy” rating on shares of Danaher Corp. in a report on Sunday, May 29th. JPMorgan Chase & Co. reiterated a “buy” rating and set a $105.00 target price on shares of Danaher Corp. in a research report on Thursday, June 30th. Jefferies Group reiterated a “buy” rating and set a $92.00 target price (down previously from $105.00) on shares of Danaher Corp. in a research report on Friday, July 15th. Argus reiterated a “buy” rating and set a $90.00 target price (down previously from $110.00) on shares of Danaher Corp. in a research report on Thursday, July 28th. Finally, Morgan Stanley reiterated a “buy” rating and set a $86.00 target price on shares of Danaher Corp. in a research report on Wednesday, August 31st. Nine equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The company has an average rating of “Buy” and an average price target of $95.22.
In related news, insider Thomas Patrick Joyce, Jr. sold 45,897 shares of the stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $81.44, for a total transaction of $3,737,851.68. Following the transaction, the insider now directly owns 179,054 shares in the company, valued at $14,582,157.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Daniel L. Comas sold 96,446 shares of the stock in a transaction dated Wednesday, July 27th. The stock was sold at an average price of $80.88, for a total value of $7,800,552.48. Following the transaction, the chief financial officer now owns 215,716 shares in the company, valued at $17,447,110.08. The disclosure for this sale can be found here. 12.60% of the stock is owned by insiders.
About Danaher Corp.
Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corp. (NYSE:DHR).
Receive News & Ratings for Danaher Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.